Testing effectiveness (Phase 2)Study completedNCT00022594
What this trial is testing
Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 50